Idexx Laboratories Supplier finance program, obligation increased by 9.4% to $6.84M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 21.1%, from $8.66M to $6.84M. Over 4 years (FY 2021 to FY 2025), Supplier finance program, obligation shows an upward trend with a 7.0% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Increasing obligations may signal aggressive working capital management or a reliance on short-term financing to support cash flow.
Represents the outstanding balance owed to financial institutions under supply chain finance or reverse factoring progra...
Increasingly common in global manufacturing; investors compare this to accounts payable to assess true trade credit terms.
other_supplier_finance_program_obligation| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $4.78M | $5.36M | $8.01M | $7.41M | $10.17M | $7.54M | $5.40M | $7.85M | $9.06M | $10.40M | $8.75M | $5.50M | $5.97M | $8.66M | $7.24M | $7.25M | $6.25M | $6.84M |
| QoQ Change | — | +12.3% | +49.3% | -7.5% | +37.3% | -25.9% | -28.4% | +45.5% | +15.4% | +14.8% | -15.9% | -37.1% | +8.4% | +45.1% | -16.4% | +0.1% | -13.7% | +9.4% |
| YoY Change | — | — | — | — | +113.0% | +40.5% | -32.6% | +6.0% | -11.0% | +38.0% | +62.1% | -29.9% | -34.1% | -16.7% | -17.3% | +31.6% | +4.7% | -21.1% |